Search: onr:"swepub:oai:prod.swepub.kib.ki.se:124026909" >
Effectiveness of di...
-
Chatzidionysiou, KKarolinska Institutet
(author)
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration
- Article/chapterEnglish2012
Publisher, publication year, extent ...
Numbers
-
LIBRIS-ID:oai:prod.swepub.kib.ki.se:124026909
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:124026909URI
-
https://doi.org/10.1136/annrheumdis-2011-200003DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
To compare the effectiveness and safety of rituximab alone or in combination with either methotrexate or leflunomide.Methods10 European registries submitted anonymised datasets with baseline, 3, 6, 9 and 12-month clinical data from patients who started rituximab.Results1195 patients were treated with rituximab plus methotrexate, 177 with rituximab plus leflunomide and 505 with rituximab alone. Significantly more patients achieved a European League Against Rheumatism good response at 6 months when treated with rituximab plus leflunomide (29.1%) compared with rituximab plus methotrexate (21.1%) and rituximab alone (19.3%; p=0.02 and p=0.01, respectively). Similar results were observed at 12 months. Adverse events occurred in 10.2%, 13.2% and 13.9% of patients on rituximab plus leflunomide, rituximab plus methotrexate and rituximab alone, respectively.ConclusionsLeflunomide is an effective and safe alternative to methotrexate as concomitant treatment with rituximab. Slightly better results were obtained by the combination of rituximab and leflunomide than rituximab and methotrexate, raising the possibility of a synergistic effect of leflunomide and rituximab.
Added entries (persons, corporate bodies, meetings, titles ...)
-
Lie, E
(author)
-
Nasonov, E
(author)
-
Lukina, G
(author)
-
Hetland, ML
(author)
-
Tarp, U
(author)
-
van Riel, PLCM
(author)
-
Nordstrom, DC
(author)
-
Gomez-Reino, J
(author)
-
Pavelka, K
(author)
-
Tomsic, M
(author)
-
Kvien, TK
(author)
-
van Vollenhoven, RFKarolinska Institutet
(author)
-
Gabay, C
(author)
-
Karolinska Institutet
(creator_code:org_t)
Related titles
-
In:Annals of the rheumatic diseases: BMJ71:3, s. 374-3771468-20600003-4967
Internet link
Find in a library
To the university's database
- By the author/editor
-
Chatzidionysiou, ...
-
Lie, E
-
Nasonov, E
-
Lukina, G
-
Hetland, ML
-
Tarp, U
-
show more...
-
van Riel, PLCM
-
Nordstrom, DC
-
Gomez-Reino, J
-
Pavelka, K
-
Tomsic, M
-
Kvien, TK
-
van Vollenhoven, ...
-
Gabay, C
-
show less...
- Articles in the publication
-
Annals of the rh ...
- By the university
-
Karolinska Institutet